Saad Mark E
- SEC CIK
- 0001295913
In the past year, 1 open-market sale filing worth $6.21M and no purchases.
Current role at each company
- AXSM Axsome Therapeutics, Inc.Directoras of Jun 10, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $6.21M
- 1 filing
- Net
- −$6.21M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Saad Mark E as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 2, 2026 (view filing) | Dec 31, 2025 | 2 days | Saad Mark EDirector | SSale | −37.6K | $165.18 | −$6.21M | −79.0%10.0K after | 2 lots10b5-1 |
| Sep 5, 2025 (view filing) | Sep 5 | Same day | Saad Mark EDirector | SSale | −9.13K | $125.07 | −$1.14M | −47.7%10.0K after | 10b5-1 |
| Sep 11, 2024 (view filing) | Sep 11 | Same day | Saad Mark EDirector | SSale | −11.0K | $91.31 | −$1.01M | −52.4%10.0K after | 10b5-1 |
| Nov 19, 2021 (view filing) | Nov 17 | 2 days | Saad Mark EDirector | PPurchase | +3.00K | $34.53 | +$103.6K | +42.8%10.0K after | |
| Nov 19, 2021 (view filing) | Nov 17 | 2 days | Saad Mark EDirector | PPurchase | +300 | $34.42 | +$10.3K | New position100 after | 3 lots |